Comparative in vitro performance evaluation of the Novopulmon® 200 Novolizer® and Budesonid-ratiopharm® Jethaler: Two novel budesonide dry powder inhalers

Pharmazie

Volumn 59, Issue 9, 2004, Pages 692-699

  De Boer, A H ^a   Gjaltema, D ^a   Hagedoorn, P ^a   Frijlink, H W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; LACTOSE;

AIRFLOW; ARTICLE; CALIBRATION; DEVICE; DRY POWDER; LASER DIFFRACTION; PARTICLE SIZE; POWDER INHALER; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE;

BRONCHODILATOR AGENTS; BUDESONIDE; CALIBRATION; EQUIPMENT DESIGN; EXCIPIENTS; LACTOSE; LASERS; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDER DIFFRACTION; POWDERS;

EID: 4644370179     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Asking L, Olsson B (1997) Calibration at different flow rates of a multi-stage liquid impinger. Aerosol Sci Technol 27: 39-49.
2. Clark AR, Egan M (1994) Modelling the deposition of inhaled powdered drug aerosols. J Aerosol Sci 25: 175-186.
3. de Boer AH, Hagedoom P, Gjaltema D, Goede J, Frijlink HW (2003) Air classifier technology (ACT) in dry powder inhalation, part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Int J Pharm 260: 187-200.
4. th Annual Conf. on dry powder inhalers. London.
5. Gerrity TR (1990) Pathophysiological and disease contraints on aerosol delivery. In: Byron PR (ed.) Respiratory drug delivery. CRC Press, Boca Raton, p. 1-38.
6. Newman S, Malik S, Hirst P, Pitcairn G, Heide A, Pabst J, Dinkelaker A, Fleischer W (2002) Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler, Resp Medicine 96: 1026-1032.
7. Rymsa B (1998) Der MAGhaler - ein neuartiger treibgasfreier Inhalator-typ Atemw-Lungenkrkh 24: 37-41.
8. Staniforth JN (1987) Order out of chaos. J Pharm Pharmacol 39: 329-334.